Subacute toxicity evaluations of LPM3480392 in rats, a full µ-opioid receptor biased agonist

Liang Ye1, Chunmei Li2, Wanglin Jiang3

  • 1School of Public Health and Management, Binzhou Medical University, Yantai, Shandong, China.

PubMed

Insights

LPM3480392, a novel MOR agonist, demonstrated good safety in a rat study. While some dose-dependent effects were observed, they were reversible, indicating favorable characteristics for potential therapeutic use.

Area of Science:

  • Pharmacology
  • Toxicology
  • Drug Development

Background:

  • Opiates mediate analgesia via G-protein signaling and adverse effects via β-arrestin pathways.
  • Oliceridine, a G protein-biased MOR agonist, shows limited safety advantages, possibly due to its modest bias.
  • LPM3480392 is a full MOR biased agonist selective for the Gi pathway over β-arrestin-2.

Purpose of the Study:

  • To evaluate the subacute toxicity of LPM3480392 in rats.
  • To assess the reversibility of any observed toxic effects.
  • To correlate toxicity findings with toxicokinetics.

Main Methods:

  • Rats received LPM3480392 (0.6, 1.2, or 2.4 mg/kg/day) or control for 4 weeks, followed by a 4-week recovery.
  • Intravenous infusions were administered three times daily.
  • Toxicokinetics and histopathology were assessed.

Main Results:

  • Major effects were MOR agonist-related (e.g., increased activity, decreased food consumption and body weight gain).
  • High dose (2.4 mg/kg/day) induced deep respiration and sporadic testis/epididymis histopathology changes.
  • LPM3480392 showed weak/no immunosuppression and decreased adrenal gland weight, with full recovery observed.

Conclusions:

  • LPM3480392 exhibits good safety characteristics in this rat subacute toxicity study.
  • Observed effects were largely reversible and related to MOR agonism.
  • The drug's full MOR bias may contribute to its favorable safety profile.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.0K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
654
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
335